Ignite Creation Date:
2024-07-17 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466122
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-07
Brief Title:
Pirtobrutinib LOXO-305 and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi
Sponsor:
Kerry Rogers
Organization:
Ohio State University Comprehensive Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-12-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-07
First Submit QC Date:
None
Study First Post Date:
2024-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-25
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL